157 related articles for article (PubMed ID: 2559738)
21. Comparison of cyclic nucleotide phosphodiesterase isoenzymes in rat and rabbit ventricular myocardium: positive inotropic and phosphodiesterase inhibitory effects of Org 30029, milrinone and rolipram.
Shahid M; Nicholson CD
Naunyn Schmiedebergs Arch Pharmacol; 1990 Dec; 342(6):698-705. PubMed ID: 1710786
[TBL] [Abstract][Full Text] [Related]
22. Relationship between inhibition of cardiac muscle phosphodiesterases, changes in cyclic nucleotide levels, and contractile response for CI-914 and other novel cardiotonics.
Weishaar RE; Quade MM; Schenden JA; Evans DB
J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(6):551-64. PubMed ID: 3003170
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of the low Km cyclic AMP phosphodiesterase and activation of the cyclic AMP system in vascular smooth muscle by milrinone.
Silver PJ; Lepore RE; O'Connor B; Lemp BM; Hamel LT; Bentley RG; Harris AL
J Pharmacol Exp Ther; 1988 Oct; 247(1):34-42. PubMed ID: 2845058
[TBL] [Abstract][Full Text] [Related]
24. The interaction of the enantiomers of carvedilol with alpha 1- and beta 1-adrenoceptors.
Nichols AJ; Sulpizio AC; Ashton DJ; Hieble JP; Ruffolo RR
Chirality; 1989; 1(4):265-70. PubMed ID: 2577144
[TBL] [Abstract][Full Text] [Related]
25. High selectivity for inhibition of phosphodiesterase III and positive inotropic effects of MCI-154 in guinea pig myocardium.
Bethke T; Meyer W; Schmitz W; Scholz H; Wenzlaff H; Armah BI; Brückner R; Raap A
J Cardiovasc Pharmacol; 1993 Jun; 21(6):847-55. PubMed ID: 7687707
[TBL] [Abstract][Full Text] [Related]
26. Multiple actions of glaucine on cyclic nucleotide phosphodiesterases, alpha 1-adrenoceptor and benzothiazepine binding site at the calcium channel.
Ivorra MD; Lugnier C; Schott C; Catret M; Noguera MA; Anselmi E; D'Ocon P
Br J Pharmacol; 1992 Jun; 106(2):387-94. PubMed ID: 1327380
[TBL] [Abstract][Full Text] [Related]
27. Interactions of three inotropic agents, ASL-7022, dobutamine and dopamine, with alpha- and beta-adrenoceptors in vitro.
Ruffolo RR; Messick K; Horng JS
Naunyn Schmiedebergs Arch Pharmacol; 1984 Jul; 326(4):317-26. PubMed ID: 6090958
[TBL] [Abstract][Full Text] [Related]
28. [Analysis of membrane current system involved in the inotropic effects mediated by alpha-adrenoceptors in the heart].
Tohse N
Hokkaido Igaku Zasshi; 1988 Sep; 63(5):754-71. PubMed ID: 2853693
[TBL] [Abstract][Full Text] [Related]
29. Inotropic selectivity of dobutamine enantiomers in the pithed rat.
Ruffolo RR; Messick K
J Pharmacol Exp Ther; 1985 Nov; 235(2):344-8. PubMed ID: 4057075
[TBL] [Abstract][Full Text] [Related]
30. [Potential cardiotonics. 14. Synthesis and in vitro positive inotropic actions of 4-morpholino-5-(4-pyridinyl)pyridine derivatives].
Hagen V; Hagen A; Krause EG; Klauschenz E
Pharmazie; 1992 Oct; 47(10):767-9. PubMed ID: 1480654
[TBL] [Abstract][Full Text] [Related]
31. Inotropic actions of BDF 9148 and DPI 201-106 and their enantiomers in guinea-pig, rat and human atria.
Hoey A; Lehmkuhl A; Sadony V; Ravens U
Eur J Pharmacol; 1993 Feb; 231(3):477-80. PubMed ID: 8449239
[TBL] [Abstract][Full Text] [Related]
32. Cardiac effects of the novel pyridazinone derivative 6-[4-[2-[3-(5-chloro-2-cyanophenoxy)-2-hydroxypropylamino]- 2- methylpropylamino]phenyl]-4,5-dihydro-5-methyl-3(2H) pyridazinone monoethyl maleate and its metabolite in isolated heart preparations of guinea pigs and dogs.
Ishimori T; Gotanda K; Sasaki T; Shinbo A; Asano H; Miyazawa K; Miyasaka K
Arzneimittelforschung; 1994 May; 44(5):583-8. PubMed ID: 7912931
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological and biochemical effects of the cardiotonic agent Org10325 in isolated cardiac and vascular tissue preparations.
Shahid M; Martorana MG; Cottney JE; Marshall RJ
Br J Pharmacol; 1990 Aug; 100(4):735-42. PubMed ID: 2169938
[TBL] [Abstract][Full Text] [Related]
34. Investigation of the positive inotropic action of 6,7-dimethoxy-3-cyano-3,4-dihydrocarbostyril.
Ferrini R; Miragoli G; Calabi ML; Santangelo F; Godfraind T; Bravo G; Casagrande C
Arzneimittelforschung; 1996 Feb; 46(2):139-45. PubMed ID: 8720302
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
[TBL] [Abstract][Full Text] [Related]
36. Interaction of the novel inotropic agent, ASL-7022, with alpha and beta adrenoceptors in the cardiovascular system of the pithed rat: comparison with dobutamine and dopamine.
Ruffolo RR; Morgan EL
J Pharmacol Exp Ther; 1984 May; 229(2):364-71. PubMed ID: 6325661
[TBL] [Abstract][Full Text] [Related]
37. 4-(4-Guanidinobenzoyl)-2-imidazolones and related compounds: phosphodiesterase inhibitors and novel cardiotonics with combined histamine H2 receptor agonist and PDE III inhibitor activity.
Glass D; Buschauer A; Tenor H; Bartel S; Will-Shahab L; Krause EG
Arch Pharm (Weinheim); 1995 Oct; 328(10):709-19. PubMed ID: 8554460
[TBL] [Abstract][Full Text] [Related]
38. New inotropic agents: milrinone analogs.
Dorigo P; Fraccarollo D; Gaion RM; Santostasi G; Borea PA; Floreani M; Mosti L; Maragno I
Gen Pharmacol; 1997 May; 28(5):781-8. PubMed ID: 9184820
[TBL] [Abstract][Full Text] [Related]
39. Investigations of the mechanism of the positive inotropic action of BDF 9148: comparison with DPI 201-106 and the enantiomers.
Raap A; Armah B; Mest HJ; Stenzel W; Schloos J; Blechacz W
J Cardiovasc Pharmacol; 1997 Feb; 29(2):164-73. PubMed ID: 9057064
[TBL] [Abstract][Full Text] [Related]
40. New milrinone analogues: in vitro study of structure-activity relationships for positive inotropic effect, antagonism towards endogenous adenosine, and inhibition of cardiac type III phosphodiesterase.
Floreani M; Fossa P; Gessi S; Mosti L; Borea PA; Dorigo P
Naunyn Schmiedebergs Arch Pharmacol; 2003 Feb; 367(2):109-18. PubMed ID: 12595951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
